Open Date
19 Feb 24
22 Feb 24
1600 shares
₹40.68 Cr
Lot Size
IPO Size
Listing At
NSE SME
Listing Date
Price Range
₹75 to ₹79
Close Date
Allotment Date
21 Feb 24
27 Feb 24
Established in 2000, Zenith Drugs Limited is engaged in the business of manufacturing and trading pharmaceutical products. The company specializes in making high-quality and affordable Medicines. The company has received FDA approval for 600+ Products.
Zenith Drugs Limited plans to utilize the raised capital from the IPO to: ● To upgrade the current manufacturing block. ● To fund the purchase of machinery & equipment to set up a new unit. ● To meet working capital requirements. ● General corporate purposes.
The book-running lead managers to the offer are: Gretex Corporate Services Limited
Disclaimer Investment/Trading in securities Market is subject to market risk, past performance is not a guarantee of future performance. The risk of loss in trading and investment in Securities markets including Equites and Derivatives can be substantial.